Addex Therapeutics (ADXN) Invested Capital (2025)
Addex Therapeutics' (ADXN) quarterly Invested Capital came in at $6.6 million in Q4 2025.
Analysis
Addex Therapeutics (ADXN) Invested Capital (2025) Analysis & Trends
Addex Therapeutics has disclosed Invested Capital across 1 years of filings, most recently posting $6.6 million for Q4 2025.
- In Q4 2025, Invested Capital changed N/A year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (changed N/A YoY), while the FY2025 annual figure was $6.4 million, changed N/A from the prior year.
- Invested Capital came in at $6.6 million for Q4 2025 at Addex Therapeutics.
- In the past five years, Invested Capital ranged from a high of $6.6 million in Q4 2025 to a low of $6.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 145.70 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 159.97 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 51.53 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 148.69 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 106.05 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 6.38 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Addex Therapeutics | 3.27 Mn | 3.27 Mn | - | - |